This inventor holds 3 USPTO granted patents. Top assignee: Mogam Biotechnology Institute. Active years: 2004-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004-2010
Title: Eun Jeong Park: Innovator in Biotechnology
Introduction
Eun Jeong Park is a prominent inventor based in Sungnam-si, South Korea. She has made significant contributions to the field of biotechnology, particularly in the development of novel proteins and therapeutic agents. With a total of three patents to her name, her work focuses on immunologically active proteins and angiogenesis inhibitors.
Latest Patents
One of her latest patents involves detoxified and immunologically active proteins, known as mutant LTs. These proteins have mutated amino acid sequences of heat-labile enterotoxin and are designed for use as immunogenic antigens for vaccination. Unlike wild-type LT, the mutant LTs do not induce toxic activities, making them promising candidates for developing a novel diarrheal vaccine for humans and animals. Additionally, the mutant LTs can enhance antibody production, which may be beneficial in preventing and treating various diseases.
Another significant patent is for a novel angiogenesis inhibitor named LK68. This protein shares an amino acid sequence with human apolipoprotein (a) kringle domains and has shown potential as an anticancer agent. LK68 inhibits endothelial cell proliferation and migration, demonstrating effectiveness in suppressing tumor-induced angiogenesis. This innovation could lead to advancements in treating angiogenesis-mediated diseases, including cancer and rheumatoid arthritis.
Career Highlights
Eun Jeong Park is affiliated with the Mogam Biotechnology Research Institute, where she continues her research and development efforts. Her work has garnered attention for its potential applications in medical science and therapeutic interventions.
Collaborations
Eun Jeong Park collaborates with notable colleagues, including Jihoon Chang and Jang Seong Kim, to further her research initiatives and enhance the impact of her inventions.
Conclusion
Eun Jeong Park's innovative contributions to biotechnology, particularly in the development of mutant LTs and LK68, highlight her role as a leading inventor in her field. Her work promises to advance medical treatments and improve health outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile